Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 29 results.
User Information
Export Records
  1. 1.   Revisiting and corrections to the annotated SRSF3 (SRp20) gene structure and RefSeq sequences from the human and mouse genomes
  2. Yu,Lulu; Majerciak,Vladimir; Jia, Rong; Zheng,Zhi-Ming
  3. Cell Insight. 2023, Apr ; 2(2): 100089.
  1. 2.   Signaling in the crowded cell
  2. Nussinov,Ruth; Tsai,Chung-Jung; Jang,Hyunbum
  3. Current Opinion in Structural Biology. 2021, Dec; 71: 43-50.
  1. 3.   PIK3Cd expression by fibroblasts promotes triple-negative breast cancer progression
  2. Gagliano, Teresa; Shah, Kalpit; Gargani, Sofia; Lao, Liyan; Alsaleem, Mansour; Chen, Jianing; Ntafis, Vasileios; Huang, Penghan; Ditsiou, Angeliki; Vella, Viviana; Yadav, Kritika; Bienkowska, Kamila; Bresciani, Giulia; Kang, Kai; Li, Leping; Carter, Philip; Benstead-Hume, Graeme; O'Hanlon,Tim; Dean,Michael; Pearl, Frances Mg; Lee, Soo Chin; Rakha, Emad A; Green, Andrew R; Kontoyiannis, Dimitris L; Song, Erwei; Stebbing, Justin; Giamas, Georgios
  3. The Journal of clinical investigation. 2020, JUN 1; 130(6): 3188-3204.
  1. 4.   The Human TET2 Gene Contains Three Distinct Promoter Regions With Differing Tissue and Developmental Specificities
  2. Lou,Hong; Li,Hongchuan; Ho, Kevin J.; Cai, Luke L.; Huang, Andy S.; Shank, Tyler R.; Verneris, Michael R.; Nickerson, Michael L.; Dean, Michael; Anderson,Steve
  3. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY. 2019, Jun 7; 7
  1. 5.   Is Nanoclustering essential for all oncogenic KRas pathways? Can it explain why wild-type KRas can inhibit its oncogenic variant?
  2. Nussinov,Ruth; Tsai,Chung-Jung; Jang,Hyunbum
  3. Seminars in Cancer Biology. 2019, FEB; 54: 114-120.
  1. 6.   Calmodulin (CaM) Activates PI3K alpha by Targeting the "Soft" CaM-Binding Motifs in Both the nSH2 and cSH2 Domains of p85 alpha
  2. Zhang,Mingzhen; Li, Zhigang; Wang, Guanqiao; Jang,Hyunbum; Sacks, David B.; Zhang, Jian; Gaponenko, Vadim; Nussinov,Ruth
  3. JOURNAL OF PHYSICAL CHEMISTRY B. 2018, Dec 13; 122(49): 11137-11146.
  1. 7.   Arl2-Mediated Allosteric Release of Farnesylated KRas4B from Shuttling Factor PDE delta
  2. Ozdemir, E. Sila; Jang, Hyunbum; Gursoy, Attila; Keskin, Ozlem; Nussinov, Ruth
  3. JOURNAL OF PHYSICAL CHEMISTRY B. 2018, Aug 2; 122(30): 7503-7513.
  1. 8.   Calmodulin and IQGAP1 activation of PI3K alpha and Akt in KRAS, HRAS and NRAS-driven cancers
  2. Nussinov, Ruth; Zhang, Mingzhen; Tsai, Chung-Jung; Jang, Hyunbum
  3. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. 2018, Jun; 0925-4439:(6, Part B, Special Issue): 2304-2314.
  1. 9.   Interaction of Calmodulin with the cSH2 Domain of the p85 Regulatory Subunit
  2. Wang, Guanqiao; Zhang, Mingzhen; Jang, Hyunbum; Lu, Shaoyong; Lin, Shizhou; Chen, Guoqiang; Nussinov, Ruth; Zhang, Jian; Gaponenko, Vadim
  3. Biochemistry. 2018, Mar 27; 57(12): 1917-1928.
  1. 10.   Dysregulated Delta Np63 alpha Inhibits Expression of Ink4a/arf, Blocks Senescence, and Promotes Malignant Conversion of Keratinocytes
  2. Ha, L. A.; Ponnamperuma, R. M.; Jay, S.; Ricci, M. S.; Weinberg, W. C.
  3. Plos One. 2011, Jul; 6(7): 13.
  1. 11.   In vitro comparison of O4-benzylfolate modulated, BCNU-induced toxicity in human bone marrow using CFU-GM and tumor cell lines
  2. Behrsing, H. P.; Furniss, M. J.; Robillard, K. A.; Tomaszewski, J. E.; Parchment, R. E.
  3. Cancer Chemotherapy and Pharmacology. 2010, May; 65(6): 1083-1091.
  1. 12.   Abnormal Placental Development and Early Embryonic Lethality in EpCAM-Null Mice
  2. Nagao, K.; Zhu, J. J.; Heneghan, M. B.; Hanson, J. C.; Morasso, M. I.; Tessarollo, L.; Mackem, S.; Udey, M. C.
  3. Plos One. 2009, Dec; 4(12): 9.
  1. 13.   Secretion and Biological Activity of Short Signal Peptide IL-15 Is Chaperoned by IL-15 Receptor Alpha In Vivo
  2. Bergamaschi, C.; Jalah, R.; Kulkarni, V.; Rosati, M.; Zhang, G. M.; Alicea, C.; Zolotukhin, A. S.; Felber, B. K.; Pavlakis, G. N.
  3. Journal of Immunology. 2009 183(5): 3064-3072.
  1. 14.   Structural dynamics of the cooperative binding of organic molecules in the human cytochrome P450 3A4
  2. Fishelovitch, D.; Hazan, C.; Shaik, S.; Wolfson, H. J.; Nussinov, R.
  3. Journal of the American Chemical Society. 2007, Feb; 129(6): 1602-1611.
  1. 15.   Repeat-region polymorphisms in the gene for the dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin related molecule: Effects on HIV-1 susceptibility
  2. Liu, H. L.; Carrington, M.; Wang, C. H.; Holte, S.; Lee, J.; Greene, B.; Hladik, F.; Koelle, D. M.; Wald, A.; Kurosawa, K.; Rinaldo, C. R.; Celum, C.; Detels, R.; Corey, L.; McElrath, M. J.; Zhu, T. F.
  3. Journal of Infectious Diseases. 2006, Mar; 193(5): 698-702.
  1. 16.   Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients
  2. Lepper, E. R.; Baker, S. D.; Permenter, M.; Ries, N.; van Schaik, R. H. N.; Schenk, P. W.; Price, D. K.; Ahn, D.; Smith, N. F.; Cusatis, G.; Ingersoll, R. G.; Bates, S. E.; Mathijssen, R. H. J.; Verweij, J.; Figg, W. D.; Sparreboom, A.
  3. Clinical Cancer Research. 2005, OCT 15; 11(20): 7398-7404.
  1. 17.   Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models
  2. Difilippantonio, S.; Celeste, A.; Fernandez-Capetillo, O.; Chen, H. T.; San Martin, B. R.; Van Laethem, F.; Yang, Y. P.; Petukhova, G. V.; Eckhaus, M.; Feigenbaum, L.; Manova, K.; Kruhlak, M.; Camerini-Otero, R. D.; Sharan, S.; Nussenzweig, M.; Nussenzweig, A.
  3. Nature Cell Biology. 2005, JUL; 7(7): 675-U56.
  1. 18.   Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKC delta-dependent increase in p27(Kip1) and decrease in retinoblastoma protein (pRb) phosphorylation
  2. Vucenik, I.; Ramakrishna, G.; Tantivejkul, K.; Anderson, L. M.; Ramljak, D.
  3. Breast Cancer Research and Treatment. 2005, MAY; 91(1): 35-45.
  1. 19.   Inactivation of ErbB3 by siRNA promotes apoptosis and attenuates growth and invasiveness of human lung adenocarcinoma cell line A549
  2. Sithanandam, G.; Fornwald, L. W.; Fields, J.; Anderson, L. M.
  3. Oncogene. 2005, MAR 10; 24(11): 1847-1859.
  1. 20.   Protein kinase C alpha-mediated chemotaxis of neutrophils requires NF-kappa B activity but is independent of TNF alpha signaling in mouse skin in vivo
  2. Cataisson, C.; Pearson, A. J.; Torgerson, S.; Nedospasov, S. A.; Yuspa, S. H.
  3. Journal of Immunology. 2005, FEB 1; 174(3): 1686-1692.
  1. 21.   Marked structural and functional heterogeneity in CXCR4: Separation of HIV-1 and SDF-I alpha responses
  2. Sloane, A. J.; Raso, V.; Dimitrov, D. S.; Xiao, X. D.; Deo, S.; Muljadi, N.; Restuccia, D.; Turville, S.; Kearney, C.; Broder, C. C.; Zoellner, H.; Cunningham, A. L.; Bendall, L.; Lynch, G. W.
  3. Immunology and Cell Biology. 2005 83(2): 129-143.
  1. 22.   Differential B cell expression of mouse Fc receptor homologs
  2. Davis, R. S.; Stephan, R. P.; Chen, C. C.; Dennis, G.; Cooper, M. D.
  3. International Immunology. 2004, SEP; 16(9): 1343-1353.
  1. 23.   Novel testis- and embryo-specific isoforms of the phosphofructokinase-1 muscle type gene
  2. Yamada, S.; Nakajima, H.; Kuehn, M. R.
  3. Biochemical and Biophysical Research Communications. 2004 316(2): 580-587.
  1. 24.   Comparative genetics and evolution of annexin A13 as the founder gene of vertebrate annexins
  2. Iglesias, J. M.; Morgan, R. O.; Jenkins, N. A.; Copeland, N. G.; Gilbert, D. J.; Fern, ez
  3. Molecular Biology and Evolution. 2002 19(5): 608-618.
  1. 25.   Identification and dynamics of a heparin-binding site in hepatocyte growth factor
  2. Zhou, H. J.; Casas-Finet, J. R.; Coats, R. H.; Kaufman, J. D.; Stahl, S. J.; Wingfield, P. T.; Rubin, J. S.; Bottaro, D. P.; Byrd, R. A.
  3. Biochemistry. 1999 38(45): 14793-14802.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel